Last Updated : July 3, 2012
Details
FilesGeneric Name:
Tolvaptan
Project Status:
Complete
Therapeutic Area:
Hyponatremia, non-hypovolemic
Manufacturer:
Otsuka Canada Pharmaceutical Inc.
Call for patient/clinician input open:
Brand Name:
Samsca
Project Line:
Reimbursement Review
Project Number:
SR0283-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Hyponatremia, non-hypovolemic
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : July 3, 2012